-
Notable Ups And Down: TrovaGene (NASDAQ:TROV), McDermott International Inc. (NYSE:MDR), Royal Dutch Shell plc (NYSE:RDS-B), Truett-Hurst (NASDAQ:THST), Threshold Pharmaceuticals (NASDAQ:THLD)
Trovagene, Inc. (NASDAQ: TROV), announced that it will report financial results for the fourth quarter and the twelve months ended December 31, 2014 on Thursday, March 12, 2015 at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific Daylight Time). On Tuesday shares of TrovaGene, Inc. (NASDAQ:TROV) closed at $6.36. McDermott International Inc. (NYSE:MDR) was awarded…
-
Why Investors Are Watching: Freeport-McMoRan Inc. (NYSE:FCX), TrovaGene (NASDAQ:TROV), Top Image Systems (NASDAQ:TISA), Boston Scientific (NYSE:BSX), Piper Jaffray Companies (NYSE:PJC)
Freeport-McMoRan Inc (NYSE:FCX) announced the results of additional production testing on Freeport-McMoRan Oil & Gas’s (FM O&G) Highlander discovery, located onshore in South Louisiana in the Inboard Lower Tertiary/Cretaceous trend. The production test, which was performed in the Cretaceous/Tuscaloosa section, utilized expanded testing equipment and indicated a flow rate of approximately 75 million cubic feet…
-
5 Active Stocks: Mohawk Industries Inc. (NYSE:MHK), Mastercard Inc (NYSE:MA), TrovaGene (NASDAQ:TROV), Facebook Inc (NASDAQ:FB), New Residential Investment Corp. (NYSE:NRZ)
On Feb. 19, Mohawk Industries Inc. (NYSE:MHK) announced 2014 fourth quarter net earnings of $147 million and diluted earnings per share (EPS) of $2.00. Excluding unusual charges, net earnings were $167 million and EPS was $2.27, a 27% increase over last year’s fourth quarter adjusted EPS and the highest Q4 adjusted EPS in the company’s…
-
Top Movers: Comcast Corporation (NASDAQ:CMCSA), TrovaGene (NASDAQ:TROV), EnteroMedics Inc. (NASDAQ:ETRM), Ericsson (NASDAQ:ERIC), Black Hills Corporation (NYSE:BKH)
Comcast (NASDAQ:CMCSA) has earned an “A-” credit rating from Morningstar. The firm’s “A-” rating indicates that the company is a low default risk. They also gave their stock a two star rating. On Wednesday shares of Comcast Corporation (NASDAQ:CMCSA) closed at $57.78. Company’s sales growth for last 5 years was 13.40% and EPS growth for…
-
Market Alert: TrovaGene (NASDAQ:TROV), Halcon Resources Corporation (NYSE:HK), IEC Electronics Corp. (NYSEMKT:IEC), EMC Corporation (NYSE:EMC), El Paso Electric Co. (NYSE:EE)
Trovagene, Inc. (NASDAQ:TROV) announced the closing of its previously announced underwritten public offering. The Company sold 5,111,110 shares of its common stock in the offering, which includes 666,666 shares that were issued upon the full exercise by the underwriters of their over-allotment option. On Wednesday shares of TrovaGene, Inc. (NASDAQ:TROV) closed at $4.89. Halcón Resources…
-
Top Morning News: Monster Worldwide (NYSE:MWW), Forbes Energy Services (NASDAQ:FES), Liberty Property Trust (NYSE:LPT), TrovaGene (NASDAQ:TROV), Royal Bancshares (NASDAQ:RBPAA)
Monster Worldwide Inc. (NYSE:MWW) reported loss of 6 cents per share (including stock-based compensation but excluding one-time items) in the fourth quarter of 2014, which compared unfavorably with the Zacks Consensus Estimate of earnings of 1 cent per share and year-ago earnings of 3 cents. On Wednesday shares of Monster Worldwide, Inc. (NYSE:MWW) closed at…
-
Stocks Swings: TrovaGene (NASDAQ:TROV), Vale S.A. (NYSE:VALE), Stanley Furniture Co. Inc. (NASDAQ:STLY), Basic Energy Services (NYSE:BAS), IDEXX Laboratories (NASDAQ:IDXX)
TrovaGene, Inc. (NASDAQ:TROV) announced that it is offering to sell shares of its common stock in an underwritten public offering. On Friday shares of TrovaGene, Inc. (NASDAQ:TROV) closed at $4.47. On 30 January, Vale S.A. (NYSE:VALE) said that it plans to slash dividends to shore up cash amid spiraling commodities prices. Vale S.A. (NYSE:VALE) in…
-
Biotech Losers In Spotlight: TrovaGene (NASDAQ:TROV), Actinium Pharmaceuticals (NYSEMKT:ATNM), Ohr Pharmaceutical (NASDAQ:OHRP), Advaxis (NASDAQ:ADXS), Kite Pharma (NASDAQ:KITE)
Trovagene, Inc. (NASDAQ: TROV), announced the pricing of an underwritten public offering of 4,444,444 shares of its common stock. The gross proceeds to Trovagene from this offering are expected to be approximately $20 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Trovagene. The offering is expected to close on…
-
5 Stock in Different Moves: TrovaGene (NASDAQ:TROV), Schlumberger Limited (NYSE:SLB), Cellcom Israel (NYSE:CEL), Perma-Fix Environmental Services (NASDAQ:PESI), Corning Inc. (NYSE:GLW)
On 21 January, TrovaGene, Inc. (NASDAQ:TROV) announced it will expand the clinical collaboration with Genomac Research Institute in Prague, Czech Republic. Trovagene Precision Cancer Monitoring SM technology will be used in two prospective clinical studies for the early detection of emerging oncogene mutations indicative of resistance to targeted therapies used to treat colorectal and lung…